Raloxifene Use for The Heart

Clinical trial NCT00190593 · COMPLETED

Trial details

NCT number: NCT00190593
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiovascular Diseases Breast Neoplasms

Start date: 1998-06-01
Enrollment: 10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.